Robert S. Chang

123 papers receiving 3.1k citations

Robert S. Chang's Hit Papers

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. 1986 · 466 citations
4660+24+48Years since publication100200300400

Peers

Robert S. Chang
Comparison fields: 5 of 154
  • Cellular and Molecular Neuroscience 767
  • Gastroenterology 177
  • Infectious Diseases 371
  • Oncology 529
  • Epidemiology 520
Replace David A. Clark with:
David A. Clark Canada
Andreas Raedler Germany
Thierry Roger Switzerland
Richard Bucala United States
Robin G. Lorenz United States
Anders Rosén Sweden
Domenico Lio Italy
Marco Carli Italy
John D. Stobo United States
George F. Lemp United States
Robert S. Chang relative to David A. Clark Canada David A. Clark's profile →
Citations per field
00.5×3.8×
David A. Clark · 1×
Citations per year

Countries citing papers authored by Robert S. Chang

Since Specialization
Citations

This map shows the geographic impact of Robert S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Chang more than expected).

Fields of papers citing papers by Robert S. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Chang. The network helps show where Robert S. Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert S. Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert S. Chang Line = papers co-authored together Robert S. Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
Hit paper breakdown →
1986466
2
Continuous Subcultivation of Epithelial-like Cells from Normal Human Tissues.
Hit paper breakdown →
1954256
3 2012242
4 1990163
5 1998149
6 1987121
7 1986107
8 200992
9 198991
10 198883
11 198982
12 199081
13 197164
14 199361
15 200957
16 201047
17 198846
18 195443
19 201241
20 198039

About Robert S. Chang

Robert S. Chang is a scholar working on Infectious Diseases, Epidemiology, Oncology, Surgery and Molecular Biology, having authored 129 papers that have together received 3.4k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (15 papers), Parvovirus B19 Infection Studies (9 papers), Virus-based gene therapy research (6 papers), Cytomegalovirus and herpesvirus research (6 papers), Herpesvirus Infections and Treatments (5 papers), Asian American and Pacific Histories (5 papers), Neuropeptides and Animal Physiology (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (767 citations), Gastroenterology (177 citations), Infectious Diseases (371 citations), Oncology (529 citations) and Epidemiology (520 citations). Robert S. Chang has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Victor J. Lotti, Joel J. Heidelbaugh, Paul C. Walker, Kevin M. Smith, Hani D. Tabba, Robert P. Geyer, H.W. Yeung, John Snyder, Maria Li Lung and Dorothy E. McComb. Their work appears in journals such as Experimental Biology and Medicine, The Journal of Experimental Medicine, American Journal of Tropical Medicine and Hygiene, Molecular Pharmacology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact